Postoperative radiotherapy for prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Organs at Risk Rectum Neoplastic Stem Cells Epithelial Cells Chromosomes, Human, Pair 8 Seminal Vesicles Pelvis

Organisms2

Mice, Nude Mice, SCID

Diseases51

Prostatic Neoplasms Neoplasm Recurrence, Local Carcinoma, Squamous Cell Radiation Injuries Head and Neck Neoplasms Breast Neoplasms Adenocarcinoma Thymus Neoplasms Neoplasm Metastasis Thymoma Mucositis Lung Neoplasms Lymphatic Metastasis Rectal Neoplasms Parotid Neoplasms Prostatic Hyperplasia Sigmoid Neoplasms Neoplasm Invasiveness Brain Neoplasms Neoplasms, Hormone-Dependent Skull Neoplasms Uterine Cervical Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Mouth Neoplasms Bone Neoplasms Salivary Gland Neoplasms Meningeal Neoplasms Prostatic Intraepithelial Neoplasia Neoplasms Carcinoma Genetic Predisposition to Disease Recurrence Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Nasopharyngeal Neoplasms Neoplasms, Radiation-Induced Neoplasms, Second Primary Stomach Neoplasms Pancreatic Neoplasms Urinary Bladder Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Prostatic Diseases Neovascularization, Pathologic Prostatitis Pelvic Neoplasms Colorectal Neoplasms Radiation Pneumonitis Hodgkin Disease

Chemicals and Drugs52

Prostate-Specific Antigen Androgen Antagonists Receptors, Androgen Androgens Cisplatin Tumor Markers, Biological Antineoplastic Agents Fluorouracil Tosyl Compounds Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Radiation-Sensitizing Agents Flutamide Taxoids Metribolone RNA, Small Interfering Cancer Vaccines Anticarcinogenic Agents DNA, Neoplasm Glutamate Carboxypeptidase II Antineoplastic Agents, Phytogenic 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Tumor Suppressor Protein p53 Nitriles Testosterone Proto-Oncogene Proteins c-akt Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Goserelin Azasteroids Phenylthiohydantoin Radiopharmaceuticals Leuprolide Paclitaxel Estramustine Tumor Suppressor Proteins Antibodies, Monoclonal Transcription Factors Racemases and Epimerases RNA, Neoplasm MicroRNAs Receptor, erbB-2 Vincristine Cholestenone 5 alpha-Reductase

Analytical, Diagnostic and Therapeutic Techniques and Equipment100

Radiotherapy, Adjuvant Radiotherapy Radiotherapy Dosage Combined Modality Therapy Postoperative Period Neoplasm Staging Postoperative Care Radiotherapy, Conformal Treatment Outcome Retrospective Studies Prognosis Dose Fractionation Disease-Free Survival Survival Rate Radiotherapy, Intensity-Modulated Follow-Up Studies Radiotherapy Planning, Computer-Assisted Survival Analysis Prostatectomy Brachytherapy Oral Surgical Procedures Radiotherapy, High-Energy Chemotherapy, Adjuvant Mastectomy Mastectomy, Modified Radical Mastectomy, Segmental Hysterectomy Antineoplastic Combined Chemotherapy Protocols Radiotherapy, Image-Guided Orchiectomy Radiotherapy, Computer-Assisted Multivariate Analysis Risk Factors Prospective Studies Early Detection of Cancer Kaplan-Meier Estimate Neck Dissection Risk Assessment Proportional Hazards Models Neoplasm Grading Cohort Studies Pneumonectomy Lymph Node Excision Xenograft Model Antitumor Assays Dose-Response Relationship, Radiation Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Immunohistochemistry Radiosurgery Digital Rectal Examination Transplantation, Heterologous Tumor Burden Risk Randomized Controlled Trials as Topic Case-Control Studies Biopsy Chemoradiotherapy Blotting, Western Gene Expression Profiling Magnetic Resonance Imaging Sensitivity and Specificity Transurethral Resection of Prostate Radiometry Incidence Biopsy, Needle SEER Program Odds Ratio Tomography, X-Ray Computed Predictive Value of Tests Radiation Dosage Particle Accelerators Palliative Care Transfection Oligonucleotide Array Sequence Analysis Registries Clinical Trials as Topic Reproducibility of Results Tissue Array Analysis Nomograms Castration Drug Administration Schedule Molecular Targeted Therapy Questionnaires Cranial Irradiation Logistic Models Polymerase Chain Reaction Drug Screening Assays, Antitumor Positron-Emission Tomography Feasibility Studies Organ Sparing Treatments Models, Biological Neoadjuvant Therapy Confidence Intervals Proton Therapy Salvage Therapy Heavy Ion Radiotherapy Treatment Failure Immunoenzyme Techniques Flow Cytometry Mass Screening

Phenomena and Processes35

Gene Expression Regulation, Neoplastic Time Factors Cell Proliferation Apoptosis Dose-Response Relationship, Radiation Genetic Predisposition to Disease Radiation Tolerance Risk Sensitivity and Specificity Drug Resistance, Neoplasm Signal Transduction Cell Survival Cell Growth Processes Down-Regulation Cell Division Genotype Odds Ratio Radiation Dosage Cell Movement Dose-Response Relationship, Drug Transfection DNA Methylation Cell Cycle Up-Regulation Promoter Regions, Genetic Nomograms Polymorphism, Genetic Mutation Gene Silencing RNA Interference Gene Fusion Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Gene Expression Base Sequence

Disciplines and Occupations3

Radiation Oncology Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science10

Radiotherapy, Conformal Survival Rate Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Computer-Assisted Incidence SEER Program Registries Questionnaires Base Sequence

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care40

Postoperative Period Postoperative Care Treatment Outcome Retrospective Studies Disease-Free Survival Radiation Injuries Survival Rate Follow-Up Studies Survival Analysis Multivariate Analysis Risk Factors Prospective Studies Kaplan-Meier Estimate Risk Assessment Proportional Hazards Models Cohort Studies Dose-Response Relationship, Radiation Watchful Waiting Risk Randomized Controlled Trials as Topic Case-Control Studies Sensitivity and Specificity Incidence SEER Program Age Factors Odds Ratio Predictive Value of Tests Radiation Dosage Palliative Care Registries Clinical Trials as Topic Reproducibility of Results National Cancer Institute (U.S.)Nomograms Questionnaires Logistic Models Feasibility Studies Confidence Intervals Treatment Failure Mass Screening

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Radiotherapy, Adjuvant Prostate Radiotherapy Radiotherapy Dosage Combined Modality Therapy Prostatic Neoplasms Postoperative Period Neoplasm Recurrence, Local Prostate-Specific Antigen Neoplasm Staging Postoperative Care Radiotherapy, Conformal Treatment Outcome Retrospective Studies Prognosis Carcinoma, Squamous Cell Dose Fractionation Disease-Free Survival Radiation Injuries Survival Rate Head and Neck Neoplasms Breast Neoplasms Radiotherapy, Intensity-Modulated Follow-Up Studies Androgen Antagonists Receptors, Androgen Radiotherapy Planning, Computer-Assisted Cell Line, Tumor Androgens Survival Analysis Adenocarcinoma Prostatectomy Brachytherapy Thymus Neoplasms Neoplasm Metastasis Thymoma Oral Surgical Procedures Radiotherapy, High-Energy Chemotherapy, Adjuvant Mucositis Mastectomy Lung Neoplasms Lymphatic Metastasis Mastectomy, Modified Radical Rectal Neoplasms Mastectomy, Segmental Parotid Neoplasms Hysterectomy Prostatic Hyperplasia Sigmoid Neoplasms Antineoplastic Combined Chemotherapy Protocols Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Radiotherapy, Image-Guided Brain Neoplasms Orchiectomy Neoplasms, Hormone-Dependent Radiotherapy, Computer-Assisted Skull Neoplasms Cisplatin Time Factors Multivariate Analysis Risk Factors Uterine Cervical Neoplasms Tumor Markers, Biological Disease Progression Prospective Studies Mice, Nude Early Detection of Cancer Kaplan-Meier Estimate Carcinoma, Non-Small-Cell Lung Mouth Neoplasms Neck Dissection Bone Neoplasms Antineoplastic Agents Salivary Gland Neoplasms Risk Assessment Meningeal Neoplasms Fluorouracil Proportional Hazards Models Prostatic Intraepithelial Neoplasia Radiation Oncology Neoplasm Grading Cohort Studies Tosyl Compounds Neoplasms Antineoplastic Agents, Hormonal Cell Proliferation Pneumonectomy Apoptosis Lymph Node Excision Tumor Cells, Cultured Carcinoma Xenograft Model Antitumor Assays Dose-Response Relationship, Radiation Neoplasm Proteins Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Androgen Receptor Antagonists Neoplasm Transplantation

No FAQ available that match "postoperative radiotherapy for prostate cancer"